| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 2,944 | 771 | 63 | | Cost of Revenue | 3,446 | 583 | 77 | | | Gross Profit | (502) | 188 | (14) | | | Operating Expenses | | Research Development | 12,472 | 8,269 | 5,192 | | Selling General and Administrative | 23,158 | 12,043 | 5,023 | | Non Recurring |
-
|
-
|
-
| | Others | 1,828 | 1,297 | 644 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (37,960) | (21,420) | (10,873) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 988 | 1,073 | 477 | | Earnings Before Interest And Taxes | (36,972) | (20,347) | (10,397) | | Interest Expense | 110 | 312 | 220 | | Income Before Tax | (37,082) | (20,658) | (10,617) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (37,082) | (20,658) | (10,617) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (37,082) | (20,658) | (10,617) | | Preferred Stock And Other Adjustments | (565) | (3,660) | (1,876) | | | Net Income Applicable To Common Shares | ($37,647) | ($24,318) | ($12,493) |
|
0.29% Nasdaq 
Income Statement
